IDH2 and oligodendroglioma: For oligodendrogliomas, which typically grow slowly (annual diameter increase of 4–6 mm), volumetric analysis (see General Management Principles) enhances risk evaluation by distinguishing indolent tumors suitable for observation or IDH-targeted therapies from those requiring aggressive treatment (17).